Exane Derivatives’s Merit Medical Systems MMSI Stock Holding History

Exane Derivatives’s Portfolio MMSI Stock Details MMSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$163	Sell	3 -3	-50%	-$183	﹤0.01%	690
2022 Q1	$399	Hold	6	–	–	﹤0.01%	894
2021 Q4	$374	Hold	6	–	–	﹤0.01%	802
2021 Q3	$431	Hold	6	–	–	﹤0.01%	952
2021 Q2	$376	Hold	6	–	–	﹤0.01%	972
2021 Q1	$359	Sell	6 -2,147	-100%	-$123K	﹤0.01%	828
2020 Q4	$120K	Buy	2,153 +145	+7%	+$7.48K	0.04%	375
2020 Q3	$87.3K	Sell	2,008 -188	-9%	-$8.5K	0.03%	316
2020 Q2	$100K	Sell	2,196 -308	-12%	-$12.4K	0.03%	295
2020 Q1	$78.2K	Buy	+2,504	New	+$89.2K	0.02%	309

Other funds holding MMSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Exane Derivatives's MMSI Position: Q2 2022 in Review

Exane Derivatives reduced its Merit Medical Systems (MMSI) stake by 50% in Q2 2022, selling an estimated $183 and leaving 3 shares worth $163. The position accounts for ﹤0.01% of the portfolio, ranked #690.

Exane Derivatives first reported a position in MMSI in Q1 2020 and has held it in 10 quarters since. The position peaked at $120K in Q4 2020. 262 funds tracked by Wall St. Rank hold MMSI as of Q2 2022.

Exane Derivatives held 3 shares of Merit Medical Systems worth $163 as of Q2 2022.
Exane Derivatives sold 3 Merit Medical Systems shares in Q2 2022, an estimated $183.
Merit Medical Systems made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #690 holding.
Exane Derivatives first reported a position in Merit Medical Systems in Q1 2020 and has held it in 10 quarters since.
Exane Derivatives's Merit Medical Systems position peaked at $120K in Q4 2020.
262 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.